These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2459361)

  • 1. The therapeutic equivalence of oral and subcutaneous/intramuscular morphine sulphate in cancer patients.
    Twycross RG
    J Palliat Care; 1988 May; 4(1-2):67-8. PubMed ID: 2459361
    [No Abstract]   [Full Text] [Related]  

  • 2. The therapeutic equivalence of i.m. and p.o. administration of morphine--1:3 or 1:6?
    Kaiko RF
    J Palliat Care; 1988 May; 4(1-2):64-6. PubMed ID: 2459360
    [No Abstract]   [Full Text] [Related]  

  • 3. Converting from oral morphine to subcutaneous diamorphine.
    Amesbury B
    Palliat Med; 2000 Mar; 14(2):165-7. PubMed ID: 10829155
    [No Abstract]   [Full Text] [Related]  

  • 4. [Continuous subcutaneous infusion of opioids in cancer patients].
    Galamba JM; Olsen AK; Crawford ME; Sjøgren P
    Ugeskr Laeger; 1995 Jul; 157(29):4126-30. PubMed ID: 7544511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain.
    Lasheen W; Walsh D; Mahmoud F; Sarhill N; Rivera N; Davis M; Lagman R; Legrand S
    Palliat Med; 2010 Jan; 24(1):9-16. PubMed ID: 19910396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversy in the management of chronic cancer pain: therapeutic equivalents of IM and PO morphine.
    Kaiko RF
    J Pain Symptom Manage; 1986; 1(1):42-5. PubMed ID: 3633303
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer.
    Davis T; Miser AW; Loprinzi CL; Kaur JS; Burnham NL; Dose AM; Ames MM
    Hosp J; 1993; 9(1):85-90. PubMed ID: 8406404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of intramuscular meptazinol and morphine in cancer patients with postoperative pain.
    Kaiko RF; Wallenstein SL; Rogers AG; Canel A; Jacobs B; Houde RW
    NIDA Res Monogr; 1984; 55():138-44. PubMed ID: 6085766
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pain treatment in advanced head and neck tumors. Pilot study with continuous subcutaneous administration of morphine].
    Gralow I; von Hornstein W; Hidding J
    Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(2):85-9. PubMed ID: 1726198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid use in palliative care of children and young people with cancer.
    Hewitt M; Goldman A; Collins GS; Childs M; Hain R
    J Pediatr; 2008 Jan; 152(1):39-44. PubMed ID: 18154896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Control of pain in patients with advanced cancer].
    Luczak J
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):343-6. PubMed ID: 1279637
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic pain of cancers. How to update and promote the subcutaneous administration of morphine].
    Vedrenne JB
    J Chir (Paris); 1993 Apr; 130(4):196-9. PubMed ID: 7688375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The narcotic equivalency index.
    Twycross RG
    World Health Forum; 1990; 11(2):201-2. PubMed ID: 2091639
    [No Abstract]   [Full Text] [Related]  

  • 15. Leading the way in African home-based palliative care. Free oral morphine has allowed expansion of model home-based palliative care in Uganda.
    Ramsay S
    Lancet; 2003 Nov; 362(9398):1812-3. PubMed ID: 14661621
    [No Abstract]   [Full Text] [Related]  

  • 16. Subarachnoid local anesthetic block does not affect morphine absorption from paired intramuscular and subcutaneous injection sites in the elderly patient.
    Ronald AL; Docherty D; Broom J; Chambers WA
    Anesth Analg; 1993 Apr; 76(4):778-82. PubMed ID: 8466016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous subcutaneous morphine to patients with terminal cancer. Analgesia at home].
    Laursen JO
    Ugeskr Laeger; 1994 Apr; 156(14):2095-6. PubMed ID: 7516101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral morphine overdose in a cancer patient antagonized by prolonged naloxone infusion.
    Upadhyay S; Jain R; Chauhan H; Gupta D; Mishra S; Bhatnagar S
    Am J Hosp Palliat Care; 2008; 25(5):401-5. PubMed ID: 18539764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral morphine prescribing patterns among inpatients with pain from advanced cancer: a prospective survey of intravenous and subcutaneous use.
    Walsh D; Perin ML; McIver B
    Am J Hosp Palliat Care; 2006; 23(5):353-9. PubMed ID: 17060302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of subcutaneous patient-controlled analgesia.
    J Pain Symptom Manage; 1989 Jun; 4(2):97-100. PubMed ID: 2471753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.